These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 12388217

  • 1. Is microvascular protection by cariporide and ischemic preconditioning causally linked to myocardial salvage?
    Reffelmann T, Kloner RA.
    Am J Physiol Heart Circ Physiol; 2003 Apr; 284(4):H1134-41. PubMed ID: 12388217
    [Abstract] [Full Text] [Related]

  • 2. Dose-dependent reduction of myocardial infarct mass in rabbits by the NHE-1 inhibitor cariporide (HOE 642).
    Linz W, Albus U, Crause P, Jung W, Weichert A, Schölkens BA, Scholz W.
    Clin Exp Hypertens; 1998 Oct; 20(7):733-49. PubMed ID: 9764718
    [Abstract] [Full Text] [Related]

  • 3. Relationship between no reflow and infarct size as influenced by the duration of ischemia and reperfusion.
    Reffelmann T, Hale SL, Li G, Kloner RA.
    Am J Physiol Heart Circ Physiol; 2002 Feb; 282(2):H766-72. PubMed ID: 11788428
    [Abstract] [Full Text] [Related]

  • 4. Reduction of myocardial infarct size by SM-198110, a novel Na+/H+ exchange inhibitor, in rabbits.
    Yamada K, Matsui K, Ogawa S, Yamamoto S, Mori M, Kitano M, Ohashi N.
    Naunyn Schmiedebergs Arch Pharmacol; 2005 May; 371(5):408-19. PubMed ID: 15902428
    [Abstract] [Full Text] [Related]

  • 5. Microvascular reperfusion injury: rapid expansion of anatomic no reflow during reperfusion in the rabbit.
    Reffelmann T, Kloner RA.
    Am J Physiol Heart Circ Physiol; 2002 Sep; 283(3):H1099-107. PubMed ID: 12181140
    [Abstract] [Full Text] [Related]

  • 6. Effects of sildenafil on myocardial infarct size, microvascular function, and acute ischemic left ventricular dilation.
    Reffelmann T, Kloner RA.
    Cardiovasc Res; 2003 Aug 01; 59(2):441-9. PubMed ID: 12909327
    [Abstract] [Full Text] [Related]

  • 7. Protection from AMP 579 can be added to that from either cariporide or ischemic preconditioning in ischemic rabbit heart.
    Xu Z, Jiao Z, Cohen MV, Downey JM.
    J Cardiovasc Pharmacol; 2002 Oct 01; 40(4):510-8. PubMed ID: 12352312
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Infarct size limitation by a new Na(+)-H+ exchange inhibitor, Hoe 642: difference from preconditioning in the role of protein kinase C.
    Miura T, Ogawa T, Suzuki K, Goto M, Shimamoto K.
    J Am Coll Cardiol; 1997 Mar 01; 29(3):693-701. PubMed ID: 9060913
    [Abstract] [Full Text] [Related]

  • 10. Na(+)/H(+)-exchange inhibition and aprotinin administration: promising tools for myocardial protection during minimally invasive CABG.
    Hendrikx M, Rega F, Jamaer L, Valkenborgh T, Gutermann H, Mees U.
    Eur J Cardiothorac Surg; 2001 May 01; 19(5):633-9. PubMed ID: 11343944
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Blockade of the Na+-Ca2+ exchanger is more efficient than blockade of the Na+-H+ exchanger for protection of the myocardium from lethal reperfusion injury.
    Matsumoto T, Miura T, Miki T, Genda S, Shimamoto K.
    Cardiovasc Drugs Ther; 2002 Jul 01; 16(4):295-301. PubMed ID: 12652098
    [Abstract] [Full Text] [Related]

  • 14. Orally administered NHE1 inhibitor cariporide reduces acute responses to coronary occlusion and reperfusion.
    Humphreys RA, Haist JV, Chakrabarti S, Feng Q, Arnold JM, Karmazyn M.
    Am J Physiol; 1999 Feb 01; 276(2):H749-57. PubMed ID: 9950878
    [Abstract] [Full Text] [Related]

  • 15. Triple therapy greatly increases myocardial salvage during ischemia/reperfusion in the in situ rat heart.
    Yang XM, Cui L, Alhammouri A, Downey JM, Cohen MV.
    Cardiovasc Drugs Ther; 2013 Oct 01; 27(5):403-12. PubMed ID: 23832692
    [Abstract] [Full Text] [Related]

  • 16. Cardioprotective effects of the Na(+)/H(+) exchange inhibitor cariporide in patients with acute anterior myocardial infarction undergoing direct PTCA.
    Rupprecht HJ, vom Dahl J, Terres W, Seyfarth KM, Richardt G, Schultheibeta HP, Buerke M, Sheehan FH, Drexler H.
    Circulation; 2000 Jun 27; 101(25):2902-8. PubMed ID: 10869261
    [Abstract] [Full Text] [Related]

  • 17. Sodium-hydrogen exchange inhibition: novel strategy to prevent myocardial injury following ischemia and reperfusion.
    Buerke M, Rupprecht HJ, vom Dahl J, Terres W, Seyfarth M, Schultheiss HP, Richardt G, Sheehan FH, Drexler H.
    Am J Cardiol; 1999 May 20; 83(10A):19G-22G. PubMed ID: 10482176
    [Abstract] [Full Text] [Related]

  • 18. Rational basis for use of sodium-hydrogen exchange inhibitors in myocardial ischemia.
    Avkiran M.
    Am J Cardiol; 1999 May 20; 83(10A):10G-17G; discussion 17G-18G. PubMed ID: 10482175
    [Abstract] [Full Text] [Related]

  • 19. Na(+)/H(+) exchange inhibitor cariporide attenuates cell injury predominantly during ischemia and not at onset of reperfusion in porcine hearts with low residual blood flow.
    Klein HH, Pich S, Bohle RM, Lindert-Heimberg S, Nebendahl K.
    Circulation; 2000 Oct 17; 102(16):1977-82. PubMed ID: 11034948
    [Abstract] [Full Text] [Related]

  • 20. Cardioprotective therapy and sodium-hydrogen exchange inhibition: current concepts and future goals.
    Menown IB, Adgey AA.
    J Am Coll Cardiol; 2001 Nov 15; 38(6):1651-3. PubMed ID: 11704376
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.